|
|
|
| home > white papers > The Importance of ADCC in Assessing Clinically Relevant Differences - Sartorius Stedim BioOutsource Ltd |
|
|
 WHITE PAPERS |
|
|
Sartorius Stedim BioOutsource Ltd
|
|
The Importance of ADCC in Assessing Clinically Relevant Differences
|
|
Biosimilars have caused a revolution in the development of biologic
drugs. The model for biosimilars is a combination of speed to market and
low cost; these are fundamental to any biosimilar development project.
The biosimilars pathway to approval is not always without difficulty,
biosimilars are still relatively new, and as each new applicant is
reviewed we are learning more and more about these molecules.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
2019 IPEC Europe Annual Excipients Forum, Malta, 31 January
Join NSF at this dynamic conference in Malta on the 31st January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe.
More info >> |
|
 |
White Papers |
 |
|
Using Device Strategy to Drive R&D Productivity
Phillips-Medisize
More info >> |
|
 |
Industry Events |
 |
Clinical Trial Supply Europe 2019
13-14 March 2019, Milan, Italy
Following
on from our largest and most engaging meeting to date, Clinical Trial Supply
Europe will be returning to Milan for its 20th year in 2019!
The
19th annual edition welcomed pharmaceutical companies across Europe who got
together to share knowledge and issues regarding clinical trial supplies, both
with regards to operational and technological challenges. Over the two days,
delegates discussed issues which affected their business in our dedicated
operational and technological streams.
More info >> |
|
|
|
